Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | 225 429 | déclaré | 15 nov. 2024 | tx 9+727 484−21 092 |
| Codiak BioSciences, Inc. | 190 000 | déclaré | 24 janv. 2023 | tx 4+490 000 |
| Advaxis, Inc. | 166 312 | déclaré | 31 déc. 2015 | tx 39+502 205−65 713 |
| Prelude Therapeutics Inc | 1 289 | déclaré | 05 oct. 2021 | tx 51+260 000−330 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 15 nov. 2024 | TAX_WITHHOLDING | RECURSION PHARMACEUTICALS, INC. | 4 187 | 6.18 USD | |
| 15 août 2024 | TAX_WITHHOLDING | RECURSION PHARMACEUTICALS, INC. | 14 146 | 6.69 USD | |
| 15 mai 2024 | TAX_WITHHOLDING | RECURSION PHARMACEUTICALS, INC. | 867 | 10.01 USD | |
| 09 févr. 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 49 768 | 0.00 USD | |
| 09 févr. 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 6 040 | 0.00 USD | |
| 09 févr. 2024 | TAX_WITHHOLDING | RECURSION PHARMACEUTICALS, INC. | 1 892 | 10.09 USD | |
| 09 févr. 2024 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 99 537 | 0.00 USD | deriv |
| 01 juin 2023 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 190 713 | 0.00 USD | |
| 01 juin 2023 | GRANT_AWARD | RECURSION PHARMACEUTICALS, INC. | 381 426 | 0.00 USD | deriv |
| 24 janv. 2023 | GRANT_AWARD | Codiak BioSciences, Inc. | 190 000 | 0.00 USD | deriv |
| 16 sept. 2022 | GRANT_AWARD | Codiak BioSciences, Inc. | 80 000 | 0.00 USD | deriv |
| 02 mai 2022 | GRANT_AWARD | Codiak BioSciences, Inc. | 200 000 | 0.00 USD | deriv |
| 02 mai 2022 | GRANT_AWARD | Codiak BioSciences, Inc. | 20 000 | 0.00 USD | deriv |
| 05 oct. 2021 | SALE | Prelude Therapeutics Inc | 1 289 | 32.06 USD | |
| 05 oct. 2021 | SALE | Prelude Therapeutics Inc | 7 803 | 31.30 USD | |
| 05 oct. 2021 | SALE | Prelude Therapeutics Inc | 5 908 | 30.26 USD | |
| 05 oct. 2021 | EXERCISE | Prelude Therapeutics Inc | 15 000 | 1.89 USD | |
| 05 oct. 2021 | EXERCISE | Prelude Therapeutics Inc | 15 000 | 0.00 USD | deriv |
| 07 sept. 2021 | SALE | Prelude Therapeutics Inc | 2 873 | 36.92 USD | |
| 07 sept. 2021 | SALE | Prelude Therapeutics Inc | 7 487 | 35.91 USD | |
| 07 sept. 2021 | EXERCISE | Prelude Therapeutics Inc | 15 000 | 1.89 USD | |
| 07 sept. 2021 | SALE | Prelude Therapeutics Inc | 4 640 | 37.79 USD | |
| 07 sept. 2021 | EXERCISE | Prelude Therapeutics Inc | 15 000 | 0.00 USD | deriv |
| 05 août 2021 | EXERCISE | Prelude Therapeutics Inc | 15 000 | 1.89 USD | |
| 05 août 2021 | SALE | Prelude Therapeutics Inc | 6 116 | 29.93 USD |